11
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Immunohistochemical analysis of cutaneous malignant melanoma: Comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody

, &
Pages 16-19 | Accepted 20 Jul 1993, Published online: 06 Jul 2009

References

  • Schmitt FC, Bacchi CE. S100 protein: is it useful as a tumour marker in diagnostic immunocytochemistry?. Histopathology 1988; 15: 281–288
  • Nakajima, T, Watanabe, S, Sato, Y, et al. Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus and its diagnostic application. Cancer 1982; 50(5)912–918
  • Ordonez NG, Xiaolong JI, Hickey RC. Comparison of HMB-45 monoclonal antibody and S100 protein in the immunohistochemical diagnosis of melanoma. Am J Clin Pathol 1988; 90: 8350–8390
  • Kahn, HJ, Marks, A, Thom, H, et al. Role of antibody to S100 protein in diagnostic pathology. Am J Clin Pathol 1983; 79(3)341–347
  • Springall, DR, Gu, J, Cocchia, D, et al. The value of S100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S100 and neuron-specific enolase antibodies. Virchows Arch A Pathol Anat Histopathol 1983; 400(3)331–343
  • Michetti, F, Dell'Anna, E, Tiberio, G, et al. Immunochemical and immunocytochemical study of S100 protein in rat adipocytes. Brain Res 1983; 262(2)352–356
  • Hagen, EC, Vennegoor, C, Schlingemann, RO, et al. Correlation of histopathological characteristics with staining patterns in human melanoma assessed by (monoclonal) antibodies reactive on paraffin sections. Histopathology 1986; 10: 689–700
  • Colombari, R, Bonetti, F, Zamboni, G, et al. Distribution of melanoma specific antibody (HMB-45) in benign and malignant melanocytic tumours. Virchows Archiv A Pathol Anat 1988; 413: 17–24
  • Xiaolong JI, Wei Hua LI. The histological distribution characteristics and diagnostic significance of three types of anti-melanoma antibodies. Chinese J Pathol 1990; 2: 90–90
  • Gown, AM, Vogel, AM, Hoak, D, et al. Monoclonal antibodies specific for melanocytic tumours distinguish subpopulations of melanocytes. Am J pathol 1986; 123(2)195–203
  • Mackie RM, Campbell I, Turbitt ML. Use of NK1 C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol 1984; 37: 367–372
  • Palmer AA, Hall BE, Lew M. A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections. Pathology 1985; 17(2)335–339

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.